Document Classification

Section Type: METHODS

Text: Sixty-five CHB patients who had HBV DNA (3) 10 (4) copies/ml, positive HBeAg, positive human leukocyte antigen (HLA) - A2, alanine aminotransferase (ALT) > 2 x upper limit of normal value (ULN) were randomly divided into two groups : treatment group (n = 33), treated with an intravenous infusion of 600 mg oxymatrine in glucose solution once a day for a month, then with a 200 mg oxymatrine oral capsule three times a day, and a 200 mg silibin meglumine tablet three times a day ; control group (n = 32) patients were treated only with silibin meglumine tablet, method and dosage were the same as those of treatment group.